Skip to main content
Signal8

Worman Glenn C.

SEC insider (Form 3/4/5 filer). CIK 0001642077. Chief Financial Officer at K2 Capital Acquisition Corp (KTWO) and 3 other issuers. 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 26, 2025. Located in GRAND CAYMAN, NY.

Companies Worman Glenn C. has filed insider reports for

  • K2 Capital Acquisition Corp (KTWO): Officer, Chief Financial Officer
  • Insight Digital Partners II (DYOR): Officer, Chief Financial Officer
  • Drugs Made In America Acquisition II Corp. (DMII): Officer, CFO
  • Drugs Made In America Acquisition Corp. (DMAA): Officer, CFO
Worman Glenn C. profile photo

Worman Glenn C.

CIK: 0001642077

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

K2 Capital Acquisition Corp logo
KTWO

K2 Capital Acquisition Corp

Officer
Insight Digital Partners II logo
DYOR

Insight Digital Partners II

Officer
Drugs Made In America Acquisition II Corp. logo
DMII

Drugs Made In America Acquisition II Corp.

Officer
Drugs Made In America Acquisition Corp. logo
DMAA

Drugs Made In America Acquisition Corp.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Drugs Made In America Acquisition II Corp. logo
    DMII

    Drugs Made In America Acquisition II Corp.

    Sep 26, 2025
    Other
    Direct
    100K shares-
  • Drugs Made In America Acquisition Corp. logo
    DMAA

    Drugs Made In America Acquisition Corp.

    Jan 29, 2025
    Other
    Direct
    100K shares-

1-2 of 2